410 related articles for article (PubMed ID: 31445233)
41. Ligand based design and synthesis of pyrazole based derivatives as selective COX-2 inhibitors.
Murahari M; Mahajan V; Neeladri S; Kumar MS; Mayur YC
Bioorg Chem; 2019 May; 86():583-597. PubMed ID: 30782576
[TBL] [Abstract][Full Text] [Related]
42. Non-acidic 1,3,4-trisubstituted-pyrazole derivatives as lonazolac analogs with promising COX-2 selectivity, anti-inflammatory activity and gastric safety profile.
Abdellatif KRA; Fadaly WAA; Elshaier YAMM; Ali WAM; Kamel GM
Bioorg Chem; 2018 Apr; 77():568-578. PubMed ID: 29475165
[TBL] [Abstract][Full Text] [Related]
43. Synthesis and biological evaluation of new pyrazolone-pyridazine conjugates as anti-inflammatory and analgesic agents.
Khalil NA; Ahmed EM; Mohamed KO; Nissan YM; Zaitone SA
Bioorg Med Chem; 2014 Apr; 22(7):2080-9. PubMed ID: 24631365
[TBL] [Abstract][Full Text] [Related]
44. Discovery of a novel COX-2 inhibitor as an orally potent anti-pyretic and anti-inflammatory drug: design, synthesis, and structure-activity relationship.
Hayashi S; Sumi Y; Ueno N; Murase A; Takada J
Biochem Pharmacol; 2011 Oct; 82(7):755-68. PubMed ID: 21741371
[TBL] [Abstract][Full Text] [Related]
45. Synthesis, molecular docking and biological evaluation of some newer 2-substituted-4-(benzo[d][1,3]dioxol-5-yl)-6-phenylpyridazin-3(2H)-ones as potential anti-inflammatory and analgesic agents.
Singh J; Saini V; Kumar A; Bansal R
Bioorg Chem; 2017 Apr; 71():201-210. PubMed ID: 28236449
[TBL] [Abstract][Full Text] [Related]
46. Heterocycles 48. Synthesis, Characterization and Biological Evaluation of Imidazo[2,1-
Cristina A; Leonte D; Vlase L; Bencze LC; Imre S; Marc G; Apan B; Mogoșan C; Zaharia V
Molecules; 2018 Sep; 23(10):. PubMed ID: 30248903
[TBL] [Abstract][Full Text] [Related]
47. Synthesis, anti-inflammatory activity and COX-1/COX-2 inhibition of novel substituted cyclic imides. Part 1: Molecular docking study.
Abdel-Aziz AA; ElTahir KE; Asiri YA
Eur J Med Chem; 2011 May; 46(5):1648-55. PubMed ID: 21388719
[TBL] [Abstract][Full Text] [Related]
48. Molecular docking and synthesis of caffeic acid analogous and its anti-inflammatory, analgesic and ulcerogenic studies.
Al-Ostoot FH; Zabiulla ; Grisha S; Mohammed YHE; Vivek HK; Ara Khanum S
Bioorg Med Chem Lett; 2021 Feb; 33():127743. PubMed ID: 33316405
[TBL] [Abstract][Full Text] [Related]
49. Synthesis, biological evaluation, docking study and ulcerogenicity profiling of some novel quinoline-2-carboxamides as dual COXs/LOX inhibitors endowed with anti-inflammatory activity.
Abdelrahman MH; Youssif BGM; Abdelgawad MA; Abdelazeem AH; Ibrahim HM; Moustafa AEGA; Treamblu L; Bukhari SNA
Eur J Med Chem; 2017 Feb; 127():972-985. PubMed ID: 27837994
[TBL] [Abstract][Full Text] [Related]
50. Synthesis, potential anti-inflammatory and analgesic activities study of (S)-N-substituted-1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxamides.
Guan LP; Xia YN; Jin QH; Liu BY; Wang SH
Bioorg Med Chem Lett; 2017 Aug; 27(15):3378-3381. PubMed ID: 28610982
[TBL] [Abstract][Full Text] [Related]
51. Cycloarta-23-ene-3beta,25-diol a pentacyclic steroid from Euphorbia spinidens, as COX inhibitor with molecular docking, and in vivo study of its analgesic and anti-inflammatory activities in male swiss mice and wistar rats.
Hajhashemi V; Ghanadian M; Palizaban A; Mahnam K; Eshaghi H; Gheisari B; Sadeghi-Aliabadi H
Prostaglandins Other Lipid Mediat; 2020 Oct; 150():106473. PubMed ID: 32634574
[TBL] [Abstract][Full Text] [Related]
52. New hybrid molecules combining benzothiophene or benzofuran with rhodanine as dual COX-1/2 and 5-LOX inhibitors: Synthesis, biological evaluation and docking study.
El-Miligy MMM; Hazzaa AA; El-Messmary H; Nassra RA; El-Hawash SAM
Bioorg Chem; 2017 Jun; 72():102-115. PubMed ID: 28390993
[TBL] [Abstract][Full Text] [Related]
53. Design, synthesis of novel isoindoline hybrids as COX-2 inhibitors: Anti-inflammatory, analgesic activities and docking study.
Labib MB; Sharkawi SMZ; El-Daly M
Bioorg Chem; 2018 Oct; 80():70-80. PubMed ID: 30005203
[TBL] [Abstract][Full Text] [Related]
54. Synthesis, pharmacological screening and in silico studies of new class of Diclofenac analogues as a promising anti-inflammatory agents.
Palkar MB; Singhai AS; Ronad PM; Vishwanathswamy AH; Boreddy TS; Veerapur VP; Shaikh MS; Rane RA; Karpoormath R
Bioorg Med Chem; 2014 May; 22(10):2855-66. PubMed ID: 24751552
[TBL] [Abstract][Full Text] [Related]
55. Investigation of indole functionalized pyrazoles and oxadiazoles as anti-inflammatory agents: Synthesis, in-vivo, in-vitro and in-silico analysis.
Kumar D; Kumar RR; Pathania S; Singh PK; Kalra S; Kumar B
Bioorg Chem; 2021 Sep; 114():105068. PubMed ID: 34130110
[TBL] [Abstract][Full Text] [Related]
56. Novel 2-phenyl-4,5,6,7-tetrahydro[b]benzothiophene analogues as selective COX-2 inhibitors: Design, synthesis, anti-inflammatory evaluation, and molecular docking studies.
Khatri CK; Indalkar KS; Patil CR; Goyal SN; Chaturbhuj GU
Bioorg Med Chem Lett; 2017 Apr; 27(8):1721-1726. PubMed ID: 28284805
[TBL] [Abstract][Full Text] [Related]
57. Potent, orally available, selective COX-2 inhibitors based on 2-imidazoline core.
Sarnpitak P; Mujumdar P; Morisseau C; Hwang SH; Hammock B; Iurchenko V; Zozulya S; Gavalas A; Geronikaki A; Ivanenkov Y; Krasavin M
Eur J Med Chem; 2014 Sep; 84():160-72. PubMed ID: 25016374
[TBL] [Abstract][Full Text] [Related]
58. Amide derivatives of [5-chloro-6-(2-chloro/fluorobenzoyl)-2-benzoxazolinone-3-yl]acetic acids as potential analgesic and anti-inflammatory compounds.
Banoglu E; Okçelik B; Kupeli E; Unlü S; Yeşilada E; Amat M; Caturla JF; Sahin MF
Arch Pharm (Weinheim); 2003 Jul; 336(4-5):251-7. PubMed ID: 12916060
[TBL] [Abstract][Full Text] [Related]
59. Novel anti-inflammatory agents based on pyridazinone scaffold; design, synthesis and in vivo activity.
Abouzid K; Bekhit SA
Bioorg Med Chem; 2008 May; 16(10):5547-56. PubMed ID: 18430576
[TBL] [Abstract][Full Text] [Related]
60. Design, synthesis and molecular docking of benzophenone conjugated with oxadiazole sulphur bridge pyrazole pharmacophores as anti inflammatory and analgesic agents.
Zabiulla ; Gulnaz AR; Mohammed YHE; Khanum SA
Bioorg Chem; 2019 Nov; 92():103220. PubMed ID: 31493708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]